{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:50:22Z","timestamp":1785768622802,"version":"3.56.0"},"reference-count":54,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>In the US and Canada, women comprise\u2009approximately one-third of people who inject drugs (PWID); however, clinical characteristics and outcomes of injection drug use complications in women are poorly described.<\/jats:p><\/jats:sec>Objective<\/jats:title>To identify clinical characteristics and outcomes of infective endocarditis (IE) among women who inject drugs (WWID).<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This is a retrospective cohort study of PWID with definite IE (per 2023 Duke\u2013International Society for Cardiovascular Infectious Diseases criteria) admitted from April 5, 2007, to March 15, 2018, at 5 tertiary-care hospitals in London, Ontario, and Regina, Saskatchewan, Canada. Data were analyzed from June 1, 2023, to August 2, 2024. Descriptive analyses were conducted for baseline characteristics at index hospitalization and stratified by sex.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was the difference in 5-year survival between female and male PWID with IE. The secondary outcome was 1-year survival. Multivariable time-dependent Cox proportional hazards regression analyses were conducted for variables of clinical importance to evaluate 5-year mortality.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 430 PWID with IE, 220 (51.2%) were women; of 332 non-PWID with IE, 101 (30.4%) were women. WWID with IE were younger than men (median [IQR] age, 31.5 [27.0-38.5] vs 38.5 [31.0-49.0] years), and 11 of 220 (5.0%) were pregnant at index hospitalization, although only 12 of 220 (5.5%) had contraceptive use documented. Women had a larger proportion of right-sided IE than men (158 of 220 women [71.8%] vs 113 of 210 men [53.8%]). WWID living in urban areas had higher mortality than WWID in rural areas (adjusted hazard ratio [aHR],\u20092.70; 95% CI, 1.15-6.34; P<\/jats:italic>\u2009=\u2009.02). Overall mortality was lower among PWID referred for substance use disorder counseling in centers with inpatient services compared with centers with only outpatient referrals (aHR,\u20090.29; 95% CI, 0.17-0.51; P<\/jats:italic>\u2009&amp;lt;\u2009.001). Overall mortality was lower with right-sided heart disease for both women (aHR,\u20090.44; 95% CI, 0.27-0.71; P<\/jats:italic>\u2009&amp;lt;\u2009.001) and men (aHR,\u20090.22; 95% CI, 0.10-0.50; P<\/jats:italic>\u2009&amp;lt;\u2009.001) and was higher with congestive heart failure for both women (aHR,\u20092.32; 95% CI, 1.29-4.18; P<\/jats:italic>\u2009=\u2009.005) and men (aHR,\u20091.73; 95% CI, 1.07-2.79; P<\/jats:italic>\u2009=\u2009.02).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cohort of PWID with IE, women were overrepresented. Reasons for women\u2019s disproportionately high IE incidence need further study. Inpatient substance use disorder services, contraception counseling, and enhanced social support for WWID living in urban areas need to be prioritized.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.37861","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T15:31:17Z","timestamp":1728055877000},"page":"e2437861","source":"Crossref","is-referenced-by-count":7,"title":["Infective Endocarditis Among Women Who Inject Drugs"],"prefix":"10.1001","volume":"7","author":[{"given":"Janica A.","family":"Adams","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Spence","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"},{"name":"Wellness Wheel Medical Clinic & Indigenous Community Research Network, Regina, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esfandiar","family":"Shojaei","sequence":"additional","affiliation":[{"name":"Lawson Health Research Institute, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarshini","family":"Thandrasisla","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmol","family":"Gupta","sequence":"additional","affiliation":[{"name":"College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hee","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Skinner","sequence":"additional","affiliation":[{"name":"Wellness Wheel Medical Clinic & Indigenous Community Research Network, Regina, Saskatchewan, Canada"},{"name":"Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Saskatchewan, Regina, Saskatchewan, Canada"},{"name":"Department of Indigenous Health and Wellness, College of Medicine, University of Saskatchewan, Regina, Saskatchewan, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silverman","sequence":"additional","affiliation":[{"name":"Lawson Health Research Institute, London, Ontario, Canada"},{"name":"Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada"},{"name":"Division of Infectious Diseases, Department of Medicine, St Joseph\u2019s Hospital, London, Ontario, Canada"},{"name":"Division of Infectious Diseases, Department of Medicine, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"issue":"6","key":"zoi241096r1","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/microorganisms9061218","article-title":"Infective endocarditis: a focus on oral microbiota.","volume":"9","author":"Del Giudice","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"zoi241096r2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.7326\/M18-2124","article-title":"Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data.","volume":"170","author":"Schranz","year":"2019","journal-title":"Ann Intern Med"},{"issue":"7","key":"zoi241096r3","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/cid\/ciz1038","article-title":"Changes in infective endocarditis admissions in Pennsylvania during the opioid epidemic.","volume":"71","author":"Meisner","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"4","key":"zoi241096r4","doi-asserted-by":"publisher","first-page":"E93","DOI":"10.1503\/cmaj.180694","article-title":"The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis.","volume":"191","author":"Weir","year":"2019","journal-title":"CMAJ"},{"issue":"1","key":"zoi241096r6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2105\/AJPH.2019.305379","article-title":"Prevalence of injecting drug use and coverage of interventions to prevent HIV and hepatitis C virus infection among people who inject drugs in Canada.","volume":"110","author":"Jacka","year":"2020","journal-title":"Am J Public Health"},{"issue":"5","key":"zoi241096r8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.14745\/ccdr.v46i05a07","article-title":"National findings from the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019.","volume":"46","author":"Tarasuk","year":"2020","journal-title":"Can Commun Dis Rep"},{"issue":"12","key":"zoi241096r9","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"5","key":"zoi241096r10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097596","article-title":"Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections.","volume":"9","author":"Lansky","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"zoi241096r11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/cid\/ciac543","article-title":"Estimated number of people who inject drugs in the United States.","volume":"76","author":"Bradley","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"2","key":"zoi241096r12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa045","article-title":"Rural-urban differences in hospitalizations for opioid use-associated infective endocarditis in the United States, 2003-2016.","volume":"7","author":"Nenninger","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"zoi241096r13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch Intern Med"},{"issue":"4","key":"zoi241096r14","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz089","article-title":"High morbidity and mortality among patients with sentinel admission for injection drug use-related infective endocarditis.","volume":"6","author":"Leahey","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"zoi241096r15","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.3390\/jcm11123514","article-title":"Sex differences in characteristics of patients with infective endocarditis: a multicenter study.","volume":"11","author":"Bhandari","year":"2022","journal-title":"J Clin Med"},{"issue":"14","key":"zoi241096r16","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1161\/CIR.0000000000001090","article-title":"Management of infective endocarditis in people who inject drugs: a scientific statement from the American Heart Association.","volume":"146","author":"Baddour","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"zoi241096r17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"zoi241096r18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/cid\/ciad271","article-title":"The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: updating the Modified Duke Criteria.","volume":"77","author":"Fowler","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"8","key":"zoi241096r19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.12974","article-title":"Risk of new bloodstream infections and mortality among people who inject drugs with infective endocarditis.","volume":"3","author":"Tan","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi241096r20","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz396","article-title":"Recurrent endocarditis in persons who inject drugs.","volume":"6","author":"Rodger","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"zoi241096r23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1177\/0962280214521348","article-title":"Multiple imputation of covariates by fully conditional specification: accommodating the substantive model.","volume":"24","author":"Bartlett","year":"2015","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"zoi241096r25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12954-020-00378-z","article-title":"Risk factors of infective endocarditis in persons who inject drugs.","volume":"17","author":"Shah","year":"2020","journal-title":"Harm Reduct J"},{"issue":"10","key":"zoi241096r26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/0895-4356(96)00180-1","article-title":"Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users.","volume":"49","author":"Spijkerman","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"zoi241096r27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12954-015-0041-6","article-title":"Women\u2019s injection drug practices in their own words: a qualitative study.","volume":"12","author":"Tuchman","year":"2015","journal-title":"Harm Reduct J"},{"key":"zoi241096r28","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1097\/QAI.0b013e3181fbf407","article-title":"Couple-based HIV prevention in the United States: advantages, gaps, and future directions.","volume":"55","author":"El-Bassel","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"zoi241096r29","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1097\/QAI.0000000000000659","article-title":"HIV, HCV and health-related harms among women who inject drugs: implications for prevention and treatment.","volume":"69","author":"Iversen","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"zoi241096r30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1053\/j.semtcvs.2018.07.016","article-title":"Recidivism is the leading cause of death among intravenous drug users who underwent cardiac surgery for infective endocarditis.","volume":"31","author":"Nguemeni Tiako","year":"2019","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"1","key":"zoi241096r31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/pubmed\/fdm072","article-title":"Are men seeking medical advice too late? contacts to general practitioners and hospital admissions in Denmark 2005.","volume":"30","author":"Juel","year":"2008","journal-title":"J Public Health (Oxf)"},{"issue":"8","key":"zoi241096r32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003320","article-title":"Do men consult less than women? an analysis of routinely collected UK general practice data.","volume":"3","author":"Wang","year":"2013","journal-title":"BMJ Open"},{"issue":"1","key":"zoi241096r34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101397","article-title":"Demographic and regional trends of infective endocarditis-related mortality in the United States, 1999 to 2019.","volume":"48","author":"Agha","year":"2023","journal-title":"Curr Probl Cardiol"},{"issue":"3","key":"zoi241096r35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230886","article-title":"Gender-based vulnerability in women who inject drugs in a harm reduction setting.","volume":"15","author":"Valencia","year":"2020","journal-title":"PLoS One"},{"issue":"9683","key":"zoi241096r36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0140-6736(09)60827-8","article-title":"Indigenous health part 2: the underlying causes of the health gap.","volume":"374","author":"King","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"zoi241096r37","doi-asserted-by":"publisher","DOI":"10.33137\/tijih.v1i2.36052","article-title":"Connections and processes: Indigenous community and identity\u2019s place in the healing journey.","volume":"1","author":"Maracle","year":"2021","journal-title":"Turt Isl J Indig Health"},{"issue":"1","key":"zoi241096r38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12954-020-00366-3","article-title":"You just have to have other models, our DNA is different: the experiences of indigenous people who use illicit drugs and\/or alcohol accessing substance use treatment.","volume":"17","author":"Lavalley","year":"2020","journal-title":"Harm Reduct J"},{"issue":"31","key":"zoi241096r39","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization: United States, 1999-2014.","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"zoi241096r42","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/01.SMJ.0000054503.18393.1E","article-title":"Endocarditis during pregnancy.","volume":"96","author":"Montoya","year":"2003","journal-title":"South Med J"},{"issue":"9","key":"zoi241096r43","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/cid\/ciab533","article-title":"Maternal and fetal outcomes associated with infective endocarditis in pregnancy.","volume":"73","author":"Dagher","year":"2021","journal-title":"Clin Infect Dis"},{"key":"zoi241096r45","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1029139","article-title":"Intergenerational residential school attendance and increased substance use among First Nation adults living off-reserve: an analysis of the aboriginal peoples survey 2017.","volume":"10","author":"Toombs","year":"2023","journal-title":"Front Public Health"},{"key":"zoi241096r46","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-2393-11-61","article-title":"High lifetime pregnancy and low contraceptive usage among sex workers who use drugs: an unmet reproductive health need.","volume":"11","author":"Duff","year":"2011","journal-title":"BMC Pregnancy Childbirth"},{"issue":"10","key":"zoi241096r47","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.16228","article-title":"Association of treatment with medications for opioid use disorder with mortality after hospitalization for injection drug use\u2013associated infective endocarditis.","volume":"3","author":"Kimmel","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi241096r48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/heart.88.1.61","article-title":"Infective endocarditis: determinants of long term outcome.","volume":"88","author":"Netzer","year":"2002","journal-title":"Heart"},{"issue":"1","key":"zoi241096r49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12872-021-01853-6","article-title":"Predictors of mortality and adverse events in patients with infective endocarditis: a retrospective real world study in a surgical centre.","volume":"21","author":"Scheggi","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"zoi241096r50","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.12659\/MSM.899360","article-title":"Gender-based long-term surgical outcome in patients with active infective aortic valve endocarditis.","volume":"22","author":"Dohmen","year":"2016","journal-title":"Med Sci Monit"},{"issue":"16","key":"zoi241096r53","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1001\/jama.2020.17694","article-title":"Analysis of drug test results before and after the US declaration of a national emergency concerning the COVID-19 outbreak.","volume":"324","author":"Wainwright","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"zoi241096r54","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1007\/s40615-021-01170-w","article-title":"Disproportionate impact of COVID-19 on racial and ethnic minority groups in the United States: a 2021 Update.","volume":"9","author":"Tai","year":"2022","journal-title":"J Racial Ethn Health Disparities"},{"key":"zoi241096r5","unstructured":"United Nations Office on Drugs and Crime. World Drug Report 2022. June 2022. Accessed February 27, 2023. https:\/\/www.unodc.org\/res\/wdr2022\/MS\/WDR22_Booklet_1.pdf"},{"key":"zoi241096r7","unstructured":"Government of Canada. Federal actions on the overdose crisis. June 2024. Accessed August 10, 2024. https:\/\/www.canada.ca\/en\/health-canada\/services\/opioids\/federal-actions\/overview.html"},{"key":"zoi241096r21","unstructured":"Catalog of Bias. Immortal time bias. May 16, 2020. Accessed March 16, 2023. https:\/\/catalogofbias.org\/biases\/immortal-time-bias\/"},{"key":"zoi241096r22","unstructured":"Therneau? T, Crowson? C, Atkinson? E. Using time dependent covariates and time dependent coefficients in the Cox model. The Comprehensive R Archive Network. June 3, 2024. Accessed August 8, 2024. https:\/\/cran.r-project.org\/web\/packages\/survival\/vignettes\/timedep.pdf"},{"key":"zoi241096r24","unstructured":"Bartlett? J, Keogh? R, Bonneville? EF, Ekstr\u00f8m? CT. smcfcs: Multiple imputation of covariates by substantive model compatible fully conditional specification. June 4, 2024. Accessed August 8, 2024. https:\/\/cran.r-project.org\/web\/packages\/smcfcs\/vignettes\/smcfcs-vignette.html"},{"key":"zoi241096r33","unstructured":"Macdonald? JA, Mansour? KA, Wynter? K, . Men\u2019s and boys\u2019 barriers to health system access: a literature review. Australian Government Department of Health and Aged Care. October 2022. Accessed August 8, 2024. https:\/\/www.health.gov.au\/sites\/default\/files\/2023-07\/men-s-and-boys-barriers-to-health-system-access-a-literature-review.pdf"},{"key":"zoi241096r40","unstructured":"Centre of Excellence for Women\u2019s Health. Women and opioids media guide. 2018. Accessed March 16, 2023. https:\/\/cewh.ca\/wp-content\/uploads\/2018\/05\/CanFASD_WomenAndOpiods_180504_1504_MediaGuide.pdf"},{"key":"zoi241096r41","unstructured":"Canadian Paediatric Society. Managing infants born to mothers who have used opioids during pregnancy. May 11, 2018. Accessed March 16, 2023. https:\/\/cps.ca\/en\/documents\/position\/opioids-during-pregnancy"},{"key":"zoi241096r44","unstructured":"American College of Obstetricians and Gynecologists. Caring for patients who have experienced trauma. April 2021. Accessed July 24, 2023. https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2021\/04\/caring-for-patients-who-have-experienced-trauma"},{"key":"zoi241096r51","unstructured":"Government of Canada. An update on the socio-economic gaps between indigenous peoples and the non-indigenous population in Canada: highlights from the 2021 census. 2023. Accessed August 10, 2024. https:\/\/www.sac-isc.gc.ca\/eng\/1690909773300\/1690909797208"},{"key":"zoi241096r52","unstructured":"Truth and Reconciliation Commission of Canada. Honouring the truth, reconciling for the future: summary of the final report of the Truth and Reconciliation Commission of Canada. 2015. Accessed August 12, 2024. https:\/\/publications.gc.ca\/collections\/collection_2015\/trc\/IR4-7-2015-eng.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2824379\/adams_2024_oi_241096_1727454020.91769.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T15:31:24Z","timestamp":1728055884000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2824379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.37861","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]}}}